BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26302497)

  • 1. Endoscopic Bypass Using Endobarrier Devices: Efficacy in Treating Obesity and Metabolic Syndrome.
    Jain D; Singhal S
    J Clin Gastroenterol; 2015; 49(10):799-803. PubMed ID: 26302497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragastric balloons appear safer and better than the endoscopic duodenojejunal bypass liners (DJBL) for preoperative weight loss in bariatric surgery.
    Gagner M
    Gastrointest Endosc; 2011 Apr; 73(4):850-1; author reply 851-2. PubMed ID: 21457827
    [No Abstract]   [Full Text] [Related]  

  • 3. [EndoBarrier for counteracting obesity and metabolic syndrome].
    Verdam FJ; Liedorp PR; Geubbels N; Schouten R; Janssen IM; Koek GH; Greve JW
    Ned Tijdschr Geneeskd; 2012; 156(13):A3844. PubMed ID: 22456287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery.
    Schouten R; Rijs CS; Bouvy ND; Hameeteman W; Koek GH; Janssen IM; Greve JW
    Ann Surg; 2010 Feb; 251(2):236-43. PubMed ID: 19858703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
    Patel N; Mohanaruban A; Ashrafian H; Le Roux C; Byrne J; Mason J; Hopkins J; Kelly J; Teare J
    Obes Surg; 2018 Jul; 28(7):1980-1989. PubMed ID: 29450844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates.
    Gersin KS; Rothstein RI; Rosenthal RJ; Stefanidis D; Deal SE; Kuwada TS; Laycock W; Adrales G; Vassiliou M; Szomstein S; Heller S; Joyce AM; Heiss F; Nepomnayshy D
    Gastrointest Endosc; 2010 May; 71(6):976-82. PubMed ID: 20304396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes.
    Patel SR; Hakim D; Mason J; Hakim N
    Surg Obes Relat Dis; 2013; 9(3):482-4. PubMed ID: 23452926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.
    Koehestanie P; de Jonge C; Berends FJ; Janssen IM; Bouvy ND; Greve JW
    Ann Surg; 2014 Dec; 260(6):984-92. PubMed ID: 25072436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Invasive methods in the treatment of obesity].
    Bene L
    Orv Hetil; 2016 May; 157(19):728-32. PubMed ID: 27133271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endobarrier: a unique but still premature concept].
    Mathus-Vliegen EM
    Ned Tijdschr Geneeskd; 2012; 156(13):A4590. PubMed ID: 22456292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bariatric procedures: an update on techniques, outcomes and complications.
    Baptista V; Wassef W
    Curr Opin Gastroenterol; 2013 Nov; 29(6):684-93. PubMed ID: 24100715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACP Journal Club: in obesity with type 2 diabetes, duodenal-jejunal bypass liners improved weight loss and HbA1c during treatment.
    Cheskin LJ; Bloomberg School Of Public Health JH; Mullin GE
    Ann Intern Med; 2015 Feb; 162(4):JC9. PubMed ID: 25686196
    [No Abstract]   [Full Text] [Related]  

  • 13. [EndoBarrier as a treatment for obesity and diabetes].
    Greve JWM; Bouvy ND
    Ned Tijdschr Geneeskd; 2018; 162():D2268. PubMed ID: 29519261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner.
    Escalona A; Pimentel F; Sharp A; Becerra P; Slako M; Turiel D; Muñoz R; Bambs C; Guzmán S; Ibáñez L; Gersin K
    Ann Surg; 2012 Jun; 255(6):1080-5. PubMed ID: 22534421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic Devices for Obesity.
    Sampath K; Dinani AM; Rothstein RI
    Curr Obes Rep; 2016 Jun; 5(2):251-61. PubMed ID: 27115879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.
    Laubner K; Riedel N; Fink K; Holl RW; Welp R; Kempe HP; Lautenbach A; Schlensak M; Stengel R; Eberl T; Dederichs F; Schwacha H; Seufert J; Aberle J
    Diabetes Obes Metab; 2018 Aug; 20(8):1868-1877. PubMed ID: 29569313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical steps for removal of duodenojejunal bypass liner (endobarrier device).
    Soares RV; Perretta S; Ignat DM; Vix M; Swanstrom LL
    Gastrointest Endosc; 2016 Dec; 84(6):1063. PubMed ID: 27311653
    [No Abstract]   [Full Text] [Related]  

  • 18. Is reimplantation of the duodenal-jejunal bypass liner feasible?
    Koehestanie P; Betzel B; Aarts EO; Janssen IM; Wahab P; Berends FJ
    Surg Obes Relat Dis; 2015; 11(5):1099-104. PubMed ID: 25979208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endoscopy in the bariatric surgery patient.
    ; Anderson MA; Gan SI; Fanelli RD; Baron TH; Banerjee S; Cash BD; Dominitz JA; Harrison ME; Ikenberry SO; Jagannath SB; Lichtenstein DR; Shen B; Lee KK; Van Guilder T; Stewart LE
    Gastrointest Endosc; 2008 Jul; 68(1):1-10. PubMed ID: 18577471
    [No Abstract]   [Full Text] [Related]  

  • 20. Endoscopic Bariatric Therapies.
    Goyal D; Watson RR
    Curr Gastroenterol Rep; 2016 Jun; 18(6):26. PubMed ID: 27098813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.